Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Whitney Way Thore has been open about her confidence journey since premiering 'My Big Fat Fabulous Life' in 2015, including ...

Food was not just her pleasure but escapism, something that Dr Jasjeet Singh Wasir, her endocrinologist and diabetologist at Medanta, understood when she consulted him last year. That’s why he put her ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Danish pharmaceutical giant Novo Nordisk launched its blockbuster weight-loss injectable semaglutide earlier this week, months after its competitor Eli Lilly’s tirzepatide hit Indian markets — and ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.